Developing faster tests for diagnosing endometriosis
Official title: RADX INNOVATION FUNNEL FOR ENDOMETRIOSIS DIAGNOSTICS - COMMERCIALIZATION CENTER
Funded at Venturewell · NIH-11219925 · Data updated 2026-11-12
This study is working to create new, easy-to-use tests for endometriosis that can be quickly available to patients, making it faster and simpler for women to get the help they need.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Venturewell NIH-funded |
| Lab location | 1 site (Hadley, United States) |
| Project start | July 15, 2024 |
| Project end | March 14, 2026 |
| Funding year | 2024 |
| Award (this year) | $801,749 |
| NIH project number | 75N92022D00013-0-759202400002-1 |
| Project ID | NIH-11219925 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals experiencing symptoms of endometriosis who may benefit from improved diagnostic methods.
✕Less likely to help
Patients who have already been diagnosed with endometriosis and are not seeking new diagnostic options may not receive direct benefits from this research.
What this research studies
This research aims to accelerate the development of innovative point-of-care diagnostic technologies for endometriosis. By leveraging technical and clinical expertise, the project seeks to streamline the commercialization process, ensuring that new diagnostic tools can be quickly brought to market. The initiative involves collaboration with specialized consultants to identify and mitigate risks throughout the development stages, ultimately enhancing the speed and efficiency of bringing these diagnostics to patients.
Why it matters
Potential benefit: If successful, this research could lead to quicker and more accurate diagnoses for individuals with endometriosis, improving their treatment options and quality of life.
How similar studies have gone: Other research initiatives focused on rapid diagnostic development have shown promise, indicating that this approach could yield significant advancements in endometriosis diagnostics.
Where this research is happening
-
Venturewell
Hadley, United States Active
Researchers
- Principal investigator: Marino, Mark — Venturewell
- Study coordinator: Marino, Mark
Related research
Other NIH-funded projects on the same topics.
-
Molecular clues to endometriosis-related infertility
This grant explores how molecular changes in endometriosis contribute to infertility, with the aim of finding better ways to diagnose and treat the condition.
-
Hormonal Influences on Inflammation in Endometriosis
A study in adult women with endometriosis looks at how hormones and immune pathways interact to influence inflammation and symptoms.
-
How genes influence endometriosis in women of different racial and ethnic backgrounds
The team will compare genetic changes in tissue from women of various races who have endometriosis to find molecular targets for better treatments.
-
Quantum diamond sensor endoscopy to map iron in endometriosis
A tiny quantum sensor built into an endoscope will map iron in endometriosis lesions to help diagnose the disease noninvasively.
-
Understanding how RPLP1 affects endometriosis and adenomyosis
A patient-focused look at how a ribosomal protein called RPLP1 may drive tissue changes in endometriosis and adenomyosis and what this could mean for future therapies.
-
CXCR4 methylation in endometriosis and its role as an early biomarker and non-hormonal therapy target
This project explores how changes in CXCR4 gene regulation may help diagnose endometriosis earlier and point toward non-hormonal treatments for the condition.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.